Low Serum Level of High-density Lipoprotein Cholesterol Is Associated with Gastric Cancer Regardless of Sex and Tumor Stage

Background/Aims HDL cholesterol (HDL-C) may have anti-tumor effects; however, the effects remain unclear. Thus, this study aimed to investigate sex- and tumor stage-specific association of hyperglycemia and HDL-C with gastric cancer. Materials and Methods We used the National Health Insurance Servic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Su Youn Nam (Autor), Jihyeon Jeong (Autor), Won Kee Lee (Autor), Seong Woo Jeon (Autor)
Formato: Libro
Publicado: Yong Chan Lee, 2022-09-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7f3b50d0dcce4da5b17f8f317c78401d
042 |a dc 
100 1 0 |a Su Youn Nam  |e author 
700 1 0 |a Jihyeon Jeong  |e author 
700 1 0 |a Won Kee Lee  |e author 
700 1 0 |a Seong Woo Jeon  |e author 
245 0 0 |a Low Serum Level of High-density Lipoprotein Cholesterol Is Associated with Gastric Cancer Regardless of Sex and Tumor Stage 
260 |b Yong Chan Lee,   |c 2022-09-01T00:00:00Z. 
500 |a 1738-3331 
500 |a 10.7704/kjhugr.2022.0023 
520 |a Background/Aims HDL cholesterol (HDL-C) may have anti-tumor effects; however, the effects remain unclear. Thus, this study aimed to investigate sex- and tumor stage-specific association of hyperglycemia and HDL-C with gastric cancer. Materials and Methods We used the National Health Insurance Service data. All participants underwent gastric cancer screening between January and December 2011. Hyperglycemia and HDL-C levels were categorized according to the World Health Organization guideline and Adult Treatment Panel III. Adjusted regression analysis was performed using ORs and 95% CIs. Results Gastric cancer was detected in 10,417 of 5.49 million individuals (2.43 million men). Hyperglycemia (OR, 1.28; 95% CI, 1.20~1.36) and low HDL-C levels (OR, 1.41; 95% CI, 1.35~1.48) were associated with gastric cancer. In the sub-analysis by sex, hyperglycemia (≥126 mg/dL) was associated with gastric cancer in both men (OR, 1.26; 95% CI, 1.18~1.36) and women (OR, 1.32; 95% CI, 1.17~1.49). Low HDL-C levels were associated with gastric cancer in both men (OR, 1.49; 95% CI, 1.40~1.58) and women (OR, 1.32; 95% CI, 1.27~1.42). In the sub-analysis by tumor stage, hyperglycemia was associated with both early (OR, 1.14; 95% CI, 1.08~1.20) and advanced gastric cancer (OR, 1.39; 95% CI, 1.26~1.55). Low HDL-C levels were also associated with early (OR, 1.34; 95% CI, 1.27~1.41) and advanced gastric cancer (OR, 1.92; 95% CI, 1.74~2.13). Conclusions Hyperglycemia and low HDL-C levels are consistently associated with gastric cancer regardless of sex or tumor stage. 
546 |a EN 
546 |a KO 
690 |a body mass index 
690 |a stomach neoplasms 
690 |a high density lipoprotein 
690 |a sex 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n The Korean Journal of Helicobacter and Upper Gastrointestinal Research, Vol 22, Iss 3, Pp 222-230 (2022) 
787 0 |n http://www.helicojournal.org/upload/pdf/kjhugr-2022-0023.pdf 
787 0 |n https://doaj.org/toc/1738-3331 
856 4 1 |u https://doaj.org/article/7f3b50d0dcce4da5b17f8f317c78401d  |z Connect to this object online.